Encarna Cruz, general director of BioSim, has participated in the panel “The Horizon of Biosimilars” within the 42nd AEFI Symposium.
Manuel García Goñi, Professor of Applied Economics at the Faculty of Economics and Business Sciences of the Complutense University of Madrid, and Jorge Mestre, Associate Professor at the Carlos III University of Madrid, focused their interventions on the benefits that biosimilars represent beyond economic savings.
